Zoetis Inc. $ZTS Shares Sold by First Horizon Advisors Inc.

First Horizon Advisors Inc. lowered its stake in shares of Zoetis Inc. (NYSE:ZTS) by 3.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,207 shares of the company’s stock after selling 614 shares during the quarter. First Horizon Advisors Inc.’s holdings in Zoetis were worth $2,995,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Brighton Jones LLC boosted its stake in Zoetis by 180.4% during the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after purchasing an additional 2,978 shares during the period. DekaBank Deutsche Girozentrale boosted its position in shares of Zoetis by 11.3% during the first quarter. DekaBank Deutsche Girozentrale now owns 370,422 shares of the company’s stock worth $60,174,000 after buying an additional 37,544 shares during the period. Flossbach Von Storch SE acquired a new position in shares of Zoetis during the first quarter worth approximately $292,000. Greenleaf Trust boosted its position in shares of Zoetis by 16.7% during the first quarter. Greenleaf Trust now owns 9,689 shares of the company’s stock worth $1,595,000 after buying an additional 1,386 shares during the period. Finally, Cornerstone Planning Group LLC boosted its position in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after buying an additional 88 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on ZTS. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. UBS Group reduced their price objective on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a report on Wednesday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Stifel Nicolaus set a $140.00 price objective on shares of Zoetis in a report on Tuesday. Finally, Argus reaffirmed a “buy” rating and issued a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Zoetis presently has a consensus rating of “Moderate Buy” and a consensus target price of $191.00.

Zoetis Stock Down 3.2%

ZTS opened at $120.47 on Thursday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The stock’s fifty day moving average is $145.63 and its 200-day moving average is $153.01. Zoetis Inc. has a one year low of $119.07 and a one year high of $181.85. The company has a market capitalization of $53.39 billion, a PE ratio of 20.73, a P/E/G ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same period in the previous year, the business earned $1.58 earnings per share. Zoetis’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.7%. Zoetis’s dividend payout ratio is currently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.